XBP1 and metabolic dysfunction-associated steatohepatitis: As a conclusion, the upregulation of NONMMUT010685 and NONMMUT050689 in NAFLD downregulates XBP1 and RIPK1, increases ACYL enzyme, and causes NASH development [101].